Search

Your search keyword '"Bosi, A"' showing total 834 results

Search Constraints

Start Over You searched for: Author "Bosi, A" Remove constraint Author: "Bosi, A" Topic medicine.disease Remove constraint Topic: medicine.disease
834 results on '"Bosi, A"'

Search Results

1. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection

2. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study

3. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity

4. Treating Type 1 Diabetes by Pancreas Transplant Alone: A Cohort Study on Actual Long-term (10 Years) Efficacy and Safety

5. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

6. Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage

7. Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes

8. Upper airway collapsibility in patients with OSA treated with continuous positive airway pressure: a retrospective preliminary study

9. Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial

10. Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized Trial

11. Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes

12. Biobanking for COVID-19 research

13. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

14. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

15. Beyond the barriers of the use of continuous subcutaneous insulin therapy in type 1 diabetes: a new opportunity from catheter-less insulin pumps

16. Non‐scarring patchy alopecia: What else, apart from alopecia areata?

17. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI)

18. Advancing the global public health agenda for NAFLD: a consensus statement

19. Risk of dementia in patients with atrial fibrillation: Short versus long follow‐up. A systematic review and meta‐analysis

20. Long lasting protective effects of early l-arginine treatment on endothelium in an in vitro study

21. Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life

22. Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease

23. Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

24. Treatment and prognosis of primary pulmonary lymphoma: A long‐term follow‐up study

25. Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke

26. Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation

27. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients

28. A workflow for patient-specific fluid–structure interaction analysis of the mitral valve: A proof of concept on a mitral regurgitation case

29. Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome

30. Effect of the Alterations in Contractility and Morphology Produced by Atrial Fibrillation on the Thrombosis Potential of the Left Atrial Appendage

31. Impact of the 8th Edition of the AJCC-TNM Staging System on Estimated Cancer-Specific Survival in Patients Aged 45–54 Years at Diagnosis with Differentiated Thyroid Carcinoma: A Single Center Report

32. Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes

33. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia

34. Urban and rural differences in frequency of fruit, vegetable, and soft drink consumption among 6–9‐year‐old children from 19 countries from the WHO European region

35. Acute severe asthma: management and treatment

36. Recovery of human type 2 diabetes beta cell function associates with transcriptomic signatures that point to novel therapeutic targets

37. Behavioral and Brain Structural Changes in Kindled Rats Induced by Coriaria Lactone/Pentylenetetrazol

38. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study

39. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

40. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

41. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

42. Enrichment of Tc1 cells and T cell resistance to suppression are associated with dysglycemia in the visceral fat in human obesity

43. Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data

44. Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk

45. DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre

46. A complete flaccid quadriparesis as early presentation of Graves’ disease

47. Suicidal ideation and suicidal attempts in patients with obsessive-compulsive tic-related disorder vs obsessive-compulsive disorder: Results of a multicenter Italian study

48. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes

49. Second primary malignancy in myelofibrosis patients treated with ruxolitinib

50. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

Catalog

Books, media, physical & digital resources